{
  "symbol": "BDX",
  "name": "Becton Dickinson",
  "sector": "Health Care",
  "industry": "Health Care Equipment",
  "date_added": "1972-09-30",
  "headquarters": "Franklin Lakes, New Jersey",
  "founded": "1897",
  "market_cap": 49680.257024,
  "pe_ratio": 33.658115,
  "forward_pe": 11.019663,
  "eps": 5.15,
  "revenue": 20867.00032,
  "profit_margin": 0.07179,
  "debt_to_equity": 76.344,
  "return_on_equity": 0.058870003,
  "dividend_yield": 2.42,
  "current_price": 173.33929443359375,
  "year_high": 249.34420942320776,
  "year_low": 162.35068007350563,
  "price_change_1d": -0.7391115003890061,
  "price_change_1w": -2.4374986097728906,
  "price_change_1m": 1.9615910546371356,
  "description": "Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion thera",
  "website": "https://www.bd.com",
  "employees": 70000,
  "exchange": "NYQ",
  "currency": "USD",
  "analyst_target_price": 217.825,
  "recommendation": 2.41176,
  "number_of_analysts": 14,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 320.55,
    "target_low": 172.0,
    "target_mean": 217.825,
    "target_median": 196.0
  },
  "last_updated": "2025-07-09T11:17:38.854747",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}